Patent ID: 11891421
Assignee: LGVI S.R.L.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC C

Claim 10:
11. A method for the treatment of a pathology or clinical condition, the method comprising administering to a subject in need of said treatment a therapeutic amount of a vector according to claim 2, wherein the activity of eNOS or the production of NO is increased and results in the amelioration or treatment of a pathology or clinical condition, wherein the pathology or clinical condition is selected from atherosclerosis, diabetes mellitus, dyslipidemia, metabolic syndrome, stroke, myocardial infarction, neurodegenerative diseases, multiple sclerosis, cognitive disorders, coronary spastic angina, thrombosis, pre-eclampsia, vasculites, inflammatory disorders, and venus insufficiency.